Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Autoimmune Disorders

Free Subscription 18.03.2024 1 Ann Neurol 6 Diabet Med 1 J Autoimmun 2 J Neuroimmunol 1 J Neurol 5 Mult Scler 1 N Engl J Med 2 Neurologia (Engl Ed) 3 Neurology 1 PLoS One 1 Proc Natl Acad Sci U S A 1 Semin Hematol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. MARGONI M, Pagani E, Meani A, Preziosa P, et al
   Cognitive Impairment Is Related to Glymphatic System Dysfunction in Pediatric Multiple Sclerosis.
   Ann Neurol. 2024 Mar 13. doi: 10.1002/ana.26911.
   PubMed         Abstract available
   
   

   
   Diabet Med

2. EMBICK R, Jackson M, Stewart R
   The impact of stigma on the management of type 1 diabetes: A systematic review.
   Diabet Med. 2024 Feb 15:e15299. doi: 10.1111/dme.15299.
   PubMed         Abstract available
   
   
3. HARROD JC, Cheung YM, Buckley L, Cromwell GE, et al
   Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer.
   Diabet Med. 2024 Jan 30:e15292. doi: 10.1111/dme.15292.
   PubMed         Abstract available
   
   
4. ZAREMBA N, Harrison A, Brown J, Allan J, et al
   Protocol for the STEADY intervention for type 1 diabetes and disordered eating: Safe management of people with Type 1 diabetes and EAting Disorders studY.
   Diabet Med. 2024 Jan 8:e15273. doi: 10.1111/dme.15273.
   PubMed         Abstract available
   
   
5. JONES CJ, Read R, O'Donnell N, Wakelin K, et al
   PRIORITY Trial: Results from a feasibility randomised controlled trial of a psychoeducational intervention for parents to prevent disordered eating in children and young people with type 1 diabetes.
   Diabet Med. 2023 Dec 15:e15263. doi: 10.1111/dme.15263.
   PubMed         Abstract available
   
   
6. KUBILAY E, Trawley S, Ward GM, Fourlanos S, et al
   Real-world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial.
   Diabet Med. 2023 Dec 10:e15264. doi: 10.1111/dme.15264.
   PubMed         Abstract available
   
   
7. HARRINGTON MP, Satherley RM, John M, O'Donnell N, et al
   Reliability and validity of a parent-reported screening tool for disordered eating in children and young people with Type 1 diabetes.
   Diabet Med. 2023 Nov 4:e15256. doi: 10.1111/dme.15256.
   PubMed         Abstract available
   
   

   
   J Autoimmun

8. HUANG W, Jin T, Zheng W, Yin Q, et al
   Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases.
   J Autoimmun. 2024;145:103188.
   PubMed         Abstract available
   
   

   
   J Neuroimmunol

9. KORAL G, Ulusoy C, Cossins J, Lazaridis K, et al
   Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice.
   J Neuroimmunol. 2023;383:578195.
   PubMed         Abstract available
   
   
10. FOGEL A, Olcer M, Goel A, Feng X, et al
    Novel biomarkers and interferon signature in secondary progressive multiple sclerosis.
    J Neuroimmunol. 2024;389:578328.
    PubMed         Abstract available
    
    

    
    J Neurol

11. VILASECA A, Farina A, Villagran-Garcia M, Pegat A, et al
    Neurological autoimmunity in melanoma patients: a comparison between those exposed and non-exposed to immune checkpoint inhibitors.
    J Neurol. 2024 Mar 11. doi: 10.1007/s00415-024-12252.
    PubMed         Abstract available
    
    

    
    Mult Scler

12. EHLING R, Seebacher B, Brenneis C
    Letter to the editor: Mobile health interventions in multiple sclerosis: A systematic review.
    Mult Scler. 2024 Mar 11:13524585241234789. doi: 10.1177/13524585241234789.
    PubMed        
    
    
13. NAKAMURA K, Sun Z, Hara-Cleaver C, Bodhinathan K, et al
    Natalizumab reduces loss of gray matter and thalamic volume in patients with relapsing-remitting multiple sclerosis: A post hoc analysis from the randomized, placebo-controlled AFFIRM trial.
    Mult Scler. 2024 Mar 12:13524585241235055. doi: 10.1177/13524585241235055.
    PubMed         Abstract available
    
    
14. JOHNSSON M, Stenberg YT, Farman HH, Blennow K, et al
    Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study.
    Mult Scler. 2024 Mar 13:13524585241237388. doi: 10.1177/13524585241237388.
    PubMed         Abstract available
    
    
15. ROCCHI C, Forcadela M, Kelly P, Linaker S, et al
    The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis.
    Mult Scler. 2024;30:345-356.
    PubMed         Abstract available
    
    
16. KUBICKI K, Stefoski D
    Iatrogenic myelodysplastic syndrome complicating multiple sclerosis: A case report.
    Mult Scler. 2024 Mar 8:13524585241235539. doi: 10.1177/13524585241235539.
    PubMed         Abstract available
    
    

    
    N Engl J Med

17. DRIVENES JL, Bygum A
    Spontaneous Oral Purpura in Immune Thrombocytopenia.
    N Engl J Med. 2024;390:1029.
    PubMed        
    
    

    
    Neurologia (Engl Ed)

18. TREJO-GABRIEL-GALAN JM
    Euthanasia and assisted suicide in neurological diseases: a systematic review.
    Neurologia (Engl Ed). 2024;39:170-177.
    PubMed         Abstract available
    
    
19. JIMENEZ-MORALES RM, Broche-Perez Y, Macias-Delgado Y, Sebrango C, et al
    Cognitive rehabilitation program in patients with multiple sclerosis: A pilot study.
    Neurologia (Engl Ed). 2024;39:135-146.
    PubMed         Abstract available
    
    

    
    Neurology

20. THAKOLWIBOON S, Dubey D
    Redefining Patient Evaluation in Anti-IgLON5 Disease: Anti-IgLON5 Disease Composite Score.
    Neurology. 2024;102:e209213.
    PubMed        
    
    
21. GAIG C, Gruter T, Heidbreder A, Sabater L, et al
    Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease.
    Neurology. 2024;102:e208101.
    PubMed         Abstract available
    
    
22. KOTHAPALLI NP, Chompoopong P, McKeon A, Dubey D, et al
    Teaching Video NeuroImage: Adaptor-Related Protein-Complex-3 Subunit beta-2 Immunoglobulin-G-Associated Autoimmune Ataxia.
    Neurology. 2024;102:e209257.
    PubMed        
    
    

    
    PLoS One

23. FLOYD L, Dhaygude A, Mitra S, Rowland C, et al
    Developing a disease-specific patient reported outcome measure to enhance understanding of the lived experiences of ANCA associated vasculitis: A protocol paper.
    PLoS One. 2024;19:e0298796.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

24. VENEGAS-SOLIS F, Staliunaite L, Rudolph E, Munch CC, et al
    A type I interferon regulatory network for human plasmacytoid dendritic cells based on heparin, membrane-bound and soluble BDCA-2.
    Proc Natl Acad Sci U S A. 2024;121:e2312404121.
    PubMed         Abstract available
    
    

    
    Semin Hematol

25. WANG SS
    Epidemiology and etiology of diffuse large B-cell lymphoma.
    Semin Hematol. 2023;60:255-266.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.